228 research outputs found
Thermally Activated Reversible Threshold Shifts in Yba\u3csub\u3e2\u3c/sub\u3eCu\u3csub\u3e3\u3c/sub\u3eO\u3csub\u3e7-δ\u3c/sub\u3e/Yttria-Stabilized Zirconia/Si Capacitors
Yba2Cu3O7-δ/yttria‐stabilized zirconia (YSZ)/silicon superconductor–insulator–semiconductor capacitors are characterized with capacitance‐voltage (C‐V) measurements at different gate‐voltage sweep rates and under bias‐temperature cycling. It is shown that ionic conduction in YSZ causes both hysteresis and stretch‐out in room‐temperature C‐V curves. A thermally activated process with an activation energy of about 39 meV in YSZ and/or at YSZ/Si interface is attributed to trapping/detrapping mechanisms in the SiOx interfacial layer between YSZ and Si. The negative mobile ions in YSZ can be moved by an applied electric field at room temperature and then ‘‘frozen’’ with decreasing temperature, giving rise to adjustable threshold voltages at low temperatures
Application of sound and temperature to control boundary-layer transition
The growth and decay of a wave packet convecting in a boundary layer over a concave-convex surface and its active control by localized surface heating are studied numerically using direct computations of the Navier-Stokes equations. The resulting sound radiations are computed using linearized Euler equations with the pressure from the Navier-Stokes solution as a time-dependent boundary condition. It is shown that on the concave portion the amplitude of the wave packet increases and its bandwidth broadens while on the convex portion some of the components in the packet are stabilized. The pressure field decays exponentially away from the surface and then algebraically, exhibiting a decay characteristic of acoustic waves in two dimensions. The far-field acoustic behavior exhibits a super-directivity type of behavior with a beaming downstream. Active control by surface heating is shown to reduce the growth of the wave packet but have little effect on acoustic far field behavior for the cases considered. Active control by sound emanating from the surface of an airfoil in the vicinity of the leading edge is experimentally investigated. The purpose is to control the separated region at high angles of attack. The results show that injection of sound at shedding frequency of the flow is effective in an increase of lift and reduction of drag
Survival following parathyroidectomy among United States dialysis patients
Survival following parathyroidectomy among United States dialysis patients.BackgroundSecondary hyperparathyroidism (SHPTH) is highly prevalent among persons with end-stage renal disease (ESRD). SHPTH has been linked to uremic bone disease, vascular calcification, and a higher risk of death. Parathyroidectomy (PTX) can dramatically reduce parathyroid hormone (PTH) and phosphate levels; however, the relationship between PTX and survival is not known.MethodsWe conducted an observational matched cohort study utilizing data from the United States Renal Database System (USRDS) in which 4558 patients undergoing a first PTX while on hemodialysis or peritoneal dialysis were individually matched by age, race, gender, cause of ESRD, dialysis duration, prior transplantation status, and dialysis modality to 4558 control patients who did not undergo PTX. Patients were followed from the date of PTX until they died or were lost to follow-up.ResultsThe 30-day postoperative mortality rate following PTX was 3.1%. Long-term relative risks of death among patients undergoing PTX were estimated to be 10% to 15% lower than those of matched control patients not undergoing surgery. Survival curves between the 2 groups crossed 587 days following PTX. Median survival was 53.4 months (95% CI: 51.2–56.4) in the PTX group, and 46.8 months (95% CI: 44.7–48.9) in the control group.ConclusionPTX was associated with higher short-term, and lower long-term, mortality rates among U.S. patients receiving chronic dialysis. Measures to attenuate SHPTH may play an important role in reducing mortality among patients with end-stage renal disease
Malaria Parasite clag3 Genes Determine Channel-Mediated Nutrient Uptake by Infected Red Blood Cells
SummaryDevelopment of malaria parasites within vertebrate erythrocytes requires nutrient uptake at the host cell membrane. The plasmodial surface anion channel (PSAC) mediates this transport and is an antimalarial target, but its molecular basis is unknown. We report a parasite gene family responsible for PSAC activity. We used high-throughput screening for nutrient uptake inhibitors to identify a compound highly specific for channels from the Dd2 line of the human pathogen P. falciparum. Inheritance of this compound's affinity in a Dd2 × HB3 genetic cross maps to a single parasite locus on chromosome 3. DNA transfection and in vitro selections indicate that PSAC-inhibitor interactions are encoded by two clag3 genes previously assumed to function in cytoadherence. These genes are conserved in plasmodia, exhibit expression switching, and encode an integral protein on the host membrane, as predicted by functional studies. This protein increases host cell permeability to diverse solutes.PaperFlic
Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints : systematic review and economic evaluation
Objective: To support a review of the guidance issued
by the National Institute for Health and Clinical
Excellence (NICE) in December 2000 by examining the
current clinical and cost-effectiveness evidence on
autologous cartilage transplantation.
Data sources: Electronic databases.
Review methods: Evidence on clinical effectiveness
was obtained from randomised trials, supplemented by
data from selected observational studies for longer
term results, and for the natural history of chondral
lesions. Because of a lack of long-term results on
outcomes such as later osteoarthritis and knee
replacement, only illustrative modelling was done, using
a range of assumptions that seemed reasonable, but
were not evidence based.
Results: Four randomised controlled trials were
included, as well as observational data from case series.
The trials studied a total of 266 patients and the
observational studies up to 101 patients. Two studies
compared autologous chondrocyte implantation (ACI)
with mosaicplasty, the third compared ACI with
microfracture, and the fourth compared matrix-guided
ACI (MACI®) with microfracture. Follow-up was 1 year
in one study, and up to 3 years in the remaining three
studies. The first trial of ACI versus mosaicplasty found
that ACI gave better results than mosaicplasty at 1 year.
Overall, 88% had excellent or good results with ACI
versus 69% with mosaicplasty. About half of the
biopsies after ACI showed hyaline cartilage. The second
trial of ACI versus mosaicplasty found little difference in
clinical outcomes at 2 years. Disappointingly, biopsies
from the ACI group showed fibrocartilage rather than
hyaline cartilage. The trial of ACI versus microfracture
also found only small differences in outcomes at
2 years. Finally, the trial of MACI versus microfracture
contained insufficient long-term results at present, but
the study does show the feasibility of doing ACI by the
MACI technique. It also suggested that after ACI, it
takes 2 years for full-thickness cartilage to be
produced. Reliable costs per quality-adjusted life-year
(QALY) could not be calculated owing to the absence
of necessary data. Simple short-term modelling
suggests that the quality of life gain from ACI versus
microfracture would have to be between 70 and 100%
greater over 2 years for it to be more cost-effective
within the £20,000–30,000 per QALY costeffectiveness
thresholds. However, if the quality of life
gains could be maintained for a decade, increments
relative to microfracture would only have to be
10–20% greater to justify additional treatment costs
within the cost-effectiveness band indicated above.
Follow-up from the trials so far has only been up to
2 years, with longer term outcomes being
uncertain.
Conclusions: There is insufficient evidence at present
to say that ACI is cost-effective compared with
microfracture or mosaicplasty. Longer term outcomes
are required. Economic modelling using some
assumptions about long-term outcomes that seem
reasonable suggests that ACI would be cost-effective because it is more likely to produce hyaline cartilage,
which is more likely to be durable and to prevent
osteoarthritis in the longer term (e.g. 20 years).
Further research is needed into earlier methods of
predicting long-term results. Basic science research is
also needed into factors that influence stem cells to
become chondrocytes and to produce high-quality
cartilage, as it may be possible to have more patients
developing hyaline cartilage after microfracture. Study
is also needed into cost-effective methods of
rehabilitation and the effect of early mobilisation on
cartilage growth
A pragmatic randomised controlled trial of hydrotherapy and land exercises on overall well being and quality of life in rheumatoid arthritis
Background \ud
Hydrotherapy is highly valued by people with rheumatoid arthritis yet few studies have compared the benefits of exercises in heated water against exercises on land. In particular, data on quality of life is rarely reported. This is especially important because patients treated with hydrotherapy often report an enhanced sense of well-being. We report a randomised controlled trial in which we compared the effects of hydrotherapy with exercises on land on overall response to treatment, physical function and quality of life in patients with rheumatoid arthritis. \ud
\ud
Methods \ud
One hundred and fifteen patients with RA were randomised to receive a weekly 30-minute session of hydrotherapy or similar exercises on land for 6 weeks. Our primary outcome was a self-rated global impression of change – a measure of treatment effect on a 7-point scale ranging from 1(very much worse) to 7 (very much better) assessed immediately on completion of treatment. Secondary outcomes including EuroQol health related quality of life, EuroQol health status valuation, HAQ, 10 metre walk time and pain scores were collected at baseline, after treatment and 3 months later. Binary outcomes were analysed by Fisher's exact test and continuous variables by Wilcoxon or Mann-Whitney tests. \ud
\ud
Results \ud
Baseline characteristics of the two groups were comparable. Significantly more patients treated with hydrotherapy (40/46, 87%) were much better or very much better than the patients treated with land exercise (19/40, 47.5%), p < 0.001 Fisher's exact test. Eleven patients allocated land exercise failed to complete treatment compared with 4 patients allocated hydrotherapy (p = 0.09). Sensitivity analyses confirmed an advantage for hydrotherapy if we assumed non-completers would all not have responded (response rates 70% versus 38%; p < 0.001) or if we assumed that non-completers would have had the same response as completers (response rates 82% versus 55% p = 0.002). Ten metre walk time improved after treatment in both cases (median pre-treatment time for both groups combined 10.9 seconds, post-treatment 9.1 s, and 3 months later 9.6 s). There was however no difference between treatment groups. Similarly there were no significant differences between groups in terms of changes to HAQ, EQ-5D utility score, EQ VAS and pain VAS. \ud
\ud
Conclusion \ud
Patients with RA treated with hydrotherapy are more likely to report feeling much better or very much better than those treated with land exercises immediately on completion of the treatment programme. This perceived benefit was not reflected by differences between groups in 10-metre walk times, functional scores, quality of life measures and pain scores
Randomised, double-blind, placebo-controlled crossover study of single-dose guanfacine in unilateral neglect following stroke
OBJECTIVE: Unilateral neglect is a poststroke disorder that impacts negatively on functional outcome and lacks established, effective treatment. This multicomponent syndrome is characterised by a directional bias of attention away from contralesional space, together with impairments in several cognitive domains, including sustained attention and spatial working memory. This study aimed to test the effects of guanfacine, a noradrenergic alpha-2A agonist, on ameliorating aspects of neglect.METHODS: Thirteen right hemisphere stroke patients with leftward neglect were included in a randomised, double-blind, placebo-controlled proof-of-concept crossover study that examined the effects of a single dose of guanfacine. Patients were tested on a computerised, time-limited cancellation paradigm, as well as tasks that independently assessed sustained attention and spatial working memory.RESULTS: On guanfacine, there was a statistically significant improvement in the total number of targets found on the cancellation task when compared with placebo (mean improvement of 5, out of a possible 64). However, there was no evidence of a change in neglect patients' directional attention bias. Furthermore, Bayesian statistical analysis revealed reliable evidence against any effects of guanfacine on search organisation and performance on our sustained attention and spatial working memory tasks.CONCLUSIONS: Guanfacine improves search in neglect by boosting the number of targets found but had no effects on directional bias or search organisation, nor did it improve sustained attention or working memory on independent tasks. Further work is necessary to determine whether longer term treatment with guanfacine may be effective for some neglect patients and whether it affects functional outcome measures.TRIAL REGISTRATION NUMBER: NCT00955253.</p
Randomised, double-blind, placebo-controlled crossover study of single-dose guanfacine in unilateral neglect following stroke
Direct Production of Furfural in One-pot Fashion from Raw Biomass Using Brønsted Acidic Ionic Liquids
The conversion of raw biomass into C5-sugars and furfural was demonstrated with the one-pot method using Brønsted acidic ionic liquids (BAILs) without any mineral acids or metal halides. Various BAILs were synthesized and characterized using NMR, FT-IR, TGA, and CHNS microanalysis and were used as the catalyst for raw biomass conversion. The remarkably high yield (i.e. 88%) of C5 sugars from bagasse can be obtained using 1-methyl-3(3-sulfopropyl)-imidazolium hydrogen sulfate ([C 3 SO 3 HMIM][HSO 4 ]) BAIL catalyst in a water medium. Similarly, the [C 3 SO 3 HMIM][HSO 4 ] BAIL also converts the bagasse into furfural with very high yield (73%) in one-pot method using a water/toluene biphasic solvent system
Overview of the Kepler Science Processing Pipeline
The Kepler Mission Science Operations Center (SOC) performs several critical
functions including managing the ~156,000 target stars, associated target
tables, science data compression tables and parameters, as well as processing
the raw photometric data downlinked from the spacecraft each month. The raw
data are first calibrated at the pixel level to correct for bias, smear induced
by a shutterless readout, and other detector and electronic effects. A
background sky flux is estimated from ~4500 pixels on each of the 84 CCD
readout channels, and simple aperture photometry is performed on an optimal
aperture for each star. Ancillary engineering data and diagnostic information
extracted from the science data are used to remove systematic errors in the
flux time series that are correlated with these data prior to searching for
signatures of transiting planets with a wavelet-based, adaptive matched filter.
Stars with signatures exceeding 7.1 sigma are subjected to a suite of
statistical tests including an examination of each star's centroid motion to
reject false positives caused by background eclipsing binaries. Physical
parameters for each planetary candidate are fitted to the transit signature,
and signatures of additional transiting planets are sought in the residual
light curve. The pipeline is operational, finding planetary signatures and
providing robust eliminations of false positives.Comment: 8 pages, 3 figure
- …